Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne

Recruiting in Palo Alto (17 mi)

Age: < 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Ablon Skin Institute Research Center

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this clinical trial is to further substantiate the effectiveness and safety of TheraClearX as a stand-alone treatment of mild to moderate acne in healthy teenagers and adults ages 12-40 over the course of 7 weeks. Participants will be asked to have TheraClearX treatments weekly for 6 sessions, attend a follow up appointment 2 weeks after the 6th session, have photos taken of their face and answer questionnaires related to their acne.

Eligibility Criteria

Inclusion Criteria

Subjects must be willing to provide verbal understanding and sign an Informed Consent Form, HIPAA Form and Photography Release Form approved by the Institutional Review Board

Subjects must be in general good health, as determined by the Investigator

Subjects must be willing to comply with study instructions and return to the clinic for required visits

+14 more

Exclusion Criteria

You have more than 100 non-inflamed acne bumps on your face (like blackheads and whiteheads).

Female subjects who are pregnant, nursing mothers, planning a pregnancy during the course of the study, or become pregnant during the study

If you are a woman, you have a history of excessive hair growth, polycystic ovarian disease, or significant problems with your menstrual cycle.

+20 more